Assessing Risk Level of Patients With Myelofibrosis


To determine risk level in myelofibrosis, prognostic models are used which assign points to various clinical and pathological factors to calculate a risk score that categorizes patients as low, intermediate, or high risk; additional information like mutations and chromosomes can further refine risk stratification.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.